Medtronic PLC closed 2.43% short of its 52-week high of $93.08, which the company reached on January 28th.

Dividend stocks have historically outperformed non-dividend payers by more than 2-to-1 over the past 50 years and have been ...

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students ...

Susan Krause of Rosemount alleges New Jersey-based Integra LifeSciences pressured her to lie to regulators. Integra says ...

Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...

Realty Income has increased its dividend for 109 quarters in a row. Brookfield Infrastructure has raised its dividend every ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Medtronic (MDT – Research Report), with a price ...

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

This was the stock's third consecutive day of gains.

Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical ...